2017
OR51 Correlation of class II antibody development with acute cellular rejection and fibrosis in pediatric liver transplantation
Bow L, Ekong U, Morotti R, Antala S, Emre S. OR51 Correlation of class II antibody development with acute cellular rejection and fibrosis in pediatric liver transplantation. Human Immunology 2017, 78: 47. DOI: 10.1016/j.humimm.2017.06.057.Peer-Reviewed Original ResearchAcute cellular rejectionClass II DSAPediatric liver transplantationLiver transplantationCellular rejectionHLA antibodiesFibrosis scoreDe novo HLA antibodiesNovo HLA antibodiesSided p valueDiagnosis of antibodyWilcoxon rank sumContinuous variablesGraft dysfunctionMean fibrosisSinusoidal fibrosisGraft functionPost transplantRejection gradeAvailable biopsiesLiver dysfunctionPatient characteristicsAntibody levelsDSA developmentSpecificity of antibodies
2016
P002 The consistent inconsistency in HLA antibody testing practices: a collaboration with the Banff workgroup
Dadhania D, Jackson A, Campbell P, Bow L, Almeshari K, Schinstock C, Cornell L, Bagnasco S, Kraus E, Cozzi E, Askar M. P002 The consistent inconsistency in HLA antibody testing practices: a collaboration with the Banff workgroup. Human Immunology 2016, 77: 41. DOI: 10.1016/j.humimm.2016.07.067.Peer-Reviewed Original ResearchDonor-specific HLA antibodiesSingle antigen beadsHLA AbsAntigen beadsNon-sensitized patientsSpecific HLA antibodiesLarge transplant centerDifferent practice patternsDiagnosis of antibodyBanff criteriaHLA antibodiesSensitization statusSurveillance biopsiesPatients 54Transplant centersCombination of assaysPatient outcomesStrong antibodyPractice patternsPatient variesTesting practicesClinical relevanceHistocompatibility laboratoriesProzone effectAntibodies